{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:02:32Z","timestamp":1789419752135,"version":"build-2803163510"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370904"],"award-info":[{"award-number":["82370904"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2022A151501257"],"award-info":[{"award-number":["2022A151501257"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"\n Background<\/jats:title>\n The global prevalence of metabolic dysfunction-associated fatty liver disease (MAFLD) is increasing annually, significantly impairing patients\u2019 quality of life. Given the limitations of existing treatments, this study aims to investigate the effects of intermittent fasting (IF) on MAFLD and its underlying mechanisms.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n \n The liver tissues of four groups of mice were analyzed by bulk RNA sequencing: normal ad libitum diet (CD group), normal IF (iCD group), high-fat ad libitum diet (HFD group) and high-fat IF group (iHFD group). Differentially expressed genes (DEGs) were identified, followed by enrichment analyses including Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), and Gene Set Enrichment Analysis (GSEA). Weighted gene co-expression network analysis (WGCNA) was used to identify related modules. The most highly correlated module genes were intersected with DEGs and analyzed by protein\u2013protein interaction(PPI) network to identify key genes. The key genes were preliminarily verified by RT-qPCR. The function of the key gene was further verified by\n in vitro<\/jats:italic>\n and\n in vivo<\/jats:italic>\n experiments.\n <\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n IF significantly improved metabolic abnormalities and hepatic lipid deposition in MAFLD mice. A total of 331 DEGs were identified between the HFD and CD group, 379 DEGs between the iHFD and HFD group, and 142 DEGs were found to be common to both comparisons. Enrichment analysis showed that DEGs were mainly enriched in pathways related to fatty acid metabolism and inflammatory responses. WGCNA identified red and blue modules are most strongly correlated with MAFLD traits. After intersecting with DEGs, 32 genes were obtained. Based on PPI network analysis, we identified five key genes. After knocking down one of the key genes, Lrg1,\n in vitro<\/jats:italic>\n and\n in vivo<\/jats:italic>\n , we confirmed that Lrg1 may promote the expression of lipogenic genes such as Srebf1, Scd1, and Fasn via the PI3K-AKT pathway, thereby accelerating MAFLD progression.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Transcriptome analysis elucidated the potential mechanism by which intermittent fasting improves MAFLD, highlighting the important role of fatty acid metabolism and inflammatory responses. Several key genes regulating MAFLD through IF were identified. Knocking down the key gene Lrg1 inhibited the expression of lipogenic genes and effectively slowed MAFLD progression.<\/jats:p>\n <\/jats:sec>","DOI":"10.3389\/fendo.2026.1754251","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T06:36:56Z","timestamp":1771223816000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Intermittent fasting ameliorates MAFLD by downregulating Lrg1: insights from bulk RNA sequencing and functional verification"],"prefix":"10.3389","volume":"17","author":[{"given":"Huafeng","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shilin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]},{"name":"Medical Research Center, The Eighth Affiliated Hospital, Southern Medical University (The First People\u2019s Hospital of Shunde, Foshan)","place":["Foshan, Guangdong, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1136\/gutjnl-2023-330595","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and Malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.cgh.2014.04.014","article-title":"Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies","volume":"13","author":"Singh","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.5604\/01.3001.0012.7188","article-title":"The evolving role of liver biopsy in non-alcoholic fatty liver disease","volume":"17","author":"Arab","year":"2018","journal-title":"Ann Hepatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v12.i8.436","article-title":"Lipidomics in non-alcoholic fatty liver disease","volume":"12","author":"Kartsoli","year":"2020","journal-title":"World J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112150-20210727-00716","article-title":"Research progress on the application of time-restricted eating in adult obesity and related metabolic diseases","volume":"56","author":"He","year":"2022","journal-title":"Zhonghua yu fang yi xue za zhi [Chinese J Prev Med]"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108403","DOI":"10.1016\/j.jnutbio.2020.108403","article-title":"Alternate-day fasting alleviates diabetes-induced glycolipid metabolism disorders: roles of FGF21 and bile acids","volume":"83","author":"Zhang","year":"2020","journal-title":"J Nutr Biochem"},{"key":"B7","doi-asserted-by":"publisher","first-page":"3566","DOI":"10.1016\/j.celrep.2020.02.051","article-title":"Multi-omics analysis of the intermittent fasting response in mice identifies an unexpected role for HNF4\u03b1","volume":"30","author":"Hatchwell","year":"2020","journal-title":"Cell Rep"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-022-07142-5","article-title":"Alternate-day fasting alleviates high fat diet induced non-alcoholic fatty liver disease through controlling PPAR\u03b1\/Fgf21 signaling","volume":"49","author":"Liu","year":"2022","journal-title":"Mol Biol Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"109146","DOI":"10.1016\/j.jnutbio.2022.109146","article-title":"Alternate-day fasting prevents non-alcoholic fatty liver disease and working memory impairment in diet-induced obese mice","volume":"110","author":"Zhang","year":"2022","journal-title":"J Nutr Biochem"},{"key":"B10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.cmet.2022.12.001","article-title":"Effect of alternate day fasting combined with aerobic exercise on non-alcoholic fatty liver disease: A randomized controlled trial","volume":"35","author":"Ezpeleta","year":"2023","journal-title":"Cell Metab"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.3390\/nu14214655","article-title":"The role of intermittent fasting in the management of nonalcoholic fatty liver disease: A narrative review","volume":"14","author":"Lavallee","year":"2022","journal-title":"Nutrients"},{"key":"B12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1186\/s12906-024-04600-4","article-title":"Network analysis and experimental verification of Salvia miltiorrhiza Bunge-Reynoutria japonica Houtt. drug pair in the treatment of non-alcoholic fatty liver disease","volume":"24","author":"Chen","year":"2024","journal-title":"BMC Complementary Med Ther"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0294236","article-title":"SRplot: A free online platform for data visualization and graphing","volume":"18","author":"Tang","year":"2023","journal-title":"PloS One"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.239","article-title":"ImageGP 2 for enhanced data visualization and reproducible analysis in biomedical research","volume":"3","author":"Chen","year":"2024","journal-title":"iMeta"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082007","article-title":"Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials","volume":"389","author":"Semnani-Azad","year":"2025","journal-title":"BMJ (Clinical Res ed)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.arr.2016.10.005","article-title":"Impact of intermittent fasting on health and disease processes","volume":"39","author":"Mattson","year":"2017","journal-title":"Ageing Res Rev"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.cmet.2024.07.004","article-title":"A microbial metabolite inhibits the HIF-2\u03b1-ceramide pathway to mediate the beneficial effects of time-restricted feeding on MASH","volume":"36","author":"Zhang","year":"2024","journal-title":"Cell Metab"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2024.01.005","article-title":"Various types of fasting diet and possible benefits in nonalcoholic fatty liver: Mechanism of actions and literature update","volume":"43","author":"Mirrazavi","year":"2024","journal-title":"Clin Nutr (Edinburgh Scotland)"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cmet.2024.04.015","article-title":"A 5:2 intermittent fasting regimen ameliorates NASH and fibrosis and blunts HCC development via hepatic PPAR\u03b1 and PCK1","volume":"36","author":"Gallage","year":"2024","journal-title":"Cell Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-nutr-052020-041327","article-title":"Cardiometabolic benefits of intermittent fasting","volume":"41","author":"Varady","year":"2021","journal-title":"Annu Rev Nutr"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.010","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma","volume":"65","author":"Zoller","year":"2016","journal-title":"Metab: Clin Exp"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2020.0261","article-title":"Serum lipocalin-2 is a potential biomarker for the clinical diagnosis of nonalcoholic steatohepatitis","volume":"27","author":"Xu","year":"2021","journal-title":"Clin Mol Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41374-021-00672-9","article-title":"Chronic mineral oil administration increases hepatic inflammation in wild type mice compared to lipocalin 2 null mice","volume":"101","author":"Borkham-Kamphorst","year":"2021","journal-title":"Lab Invest"},{"key":"B24","doi-asserted-by":"publisher","first-page":"101452","DOI":"10.1016\/j.molmet.2022.101452","article-title":"Disrupted liver oxidative metabolism in glycine N-methyltransferase-deficient mice is mitigated by dietary methionine restriction","volume":"58","author":"Rome","year":"2022","journal-title":"Mol Metab"},{"key":"B25","doi-asserted-by":"publisher","first-page":"126025","DOI":"10.1016\/j.ijbiomac.2023.126025","article-title":"FOXO1 regulates the formation of bovine fat by targeting CD36 and STEAP4","volume":"248","author":"Song","year":"2023","journal-title":"Int J Biol Macromol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"115428","DOI":"10.1016\/j.biopha.2023.115428","article-title":"Inflammatory response to bacterial lipopolysaccharide drives iron accumulation in human\u00a0adipocytes","volume":"166","author":"Oliveras-Ca\u00f1ellas","year":"2023","journal-title":"Biomed Pharmacother = Biomed Pharmacotherapie"},{"key":"B27","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13098-018-0307-8","article-title":"Dietary fat stimulates development of NAFLD more potently than dietary fructose in Sprague-Dawley rats","volume":"10","author":"Jensen","year":"2018","journal-title":"Diabetol Metab Syndr"},{"key":"B28","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/s41598-018-37406-9","article-title":"Relationships of haptoglobin phenotypes with systemic inflammation and the severity of chronic obstructive pulmonary disease","volume":"9","author":"Lee","year":"2019","journal-title":"Sci Rep"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/s41467-025-56524-3","article-title":"Fucosylated haptoglobin promotes inflammation via Mincle in sepsis: an observational study","volume":"16","author":"Roh","year":"2025","journal-title":"Nat Commun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s11033-025-10669-y","article-title":"LRG1 in cancer: mechanisms, potential therapeutic target, and use in clinical diagnosis","volume":"52","author":"Osorio-Antonio","year":"2025","journal-title":"Mol Biol Rep"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.05.024","article-title":"Revealing the multiple faces of LRG1: gene expression, structure, function, and therapeutic potential","volume":"80","author":"Wang","year":"2025","journal-title":"J Adv Res"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1172\/JCI148545","article-title":"LRG1 is an adipokine that mediates obesity-induced hepatosteatosis and insulin resistance","volume":"131","author":"He","year":"2021","journal-title":"J Clin Invest"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242216537","article-title":"Leucine-rich alpha-2 glycoprotein 1 accumulates in complicated atherosclerosis and promotes calcification","volume":"24","author":"Grzesiak","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2024.1386177","article-title":"The disruptive role of LRG1 on the vasculature and perivascular microenvironment","volume":"11","author":"Dritsoula","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001018","article-title":"Endothelial RUNX3 controls LSEC dysfunction and angiocrine LRG1 signaling to prevent liver fibrosis","volume":"81","author":"Ojha","year":"2025","journal-title":"Hepatol (Baltimore Md)"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3390\/biom14111474","article-title":"Serum leucine-rich alpha-2 glycoprotein 1 levels in patients with lipodystrophy syndromes","volume":"14","author":"Krienke","year":"2024","journal-title":"Biomolecules"},{"key":"B37","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/s12551-014-0158-y","article-title":"The role of TGF\u03b21 and LRG1 in cardiac remodelling and heart failure","volume":"7","author":"Song","year":"2015","journal-title":"Biophys Rev"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/nature12345","article-title":"LRG1 promotes angiogenesis by modulating endothelial TGF-\u03b2 signalling","volume":"499","author":"Wang","year":"2013","journal-title":"Nature"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105610","article-title":"Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with Nonalcoholic Fatty Liver Disease","volume":"9","author":"Tarantino","year":"2014","journal-title":"PloS One"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.719750","article-title":"Intermittent fasting inhibits high-fat diet-induced atherosclerosis by ameliorating hypercholesterolemia and reducing monocyte chemoattraction","volume":"12","author":"Chen","year":"2021","journal-title":"Front Pharmacol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"11370","DOI":"10.1038\/s41467-025-66366-8","article-title":"Cardiometabolic and molecular adaptations to 6-month intermittent fasting in middle-aged men and women with overweight: secondary outcomes of a randomized controlled trial","volume":"16","author":"Barve","year":"2025","journal-title":"Nat Commun"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-024-01314-9","article-title":"Intermittent fasting regulates metabolic homeostasis and improves cardiovascular health","volume":"82","author":"Diab","year":"2024","journal-title":"Cell Biochem Biophys"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2405845121","article-title":"LRG1 promotes atherosclerosis by inducing macrophage M1-like polarization","volume":"121","author":"Wang","year":"2024","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-024-06331-0","article-title":"Diet-enhanced LRG1 expression promotes insulin hypersecretion and ER stress in pancreatic beta cells","volume":"68","author":"Morales","year":"2025","journal-title":"Diabetologia"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1754251\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T11:28:13Z","timestamp":1771932493000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1754251\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,16]]},"references-count":44,"alternative-id":["10.3389\/fendo.2026.1754251"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1754251","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,16]]},"article-number":"1754251"}}